Similar articles

• Membrane-active polypeptides from snake venom: cardiotoxins and haemocytotoxins.

  Condrea E. Condrea E. Experientia. 1974 Feb 15;30(2):121-9. doi: 10.1007/BF01927688. Experientia. 1974. PMID: 4592382 Review. No abstract available.
• Osmotic and non-osmotic components of the haemolysis induced by the direct lytic factor (DLF) of cobra venom.

  Lankisch PG, Damerau B, Vogt W. Lankisch PG, et al. Naunyn Schmiedebergs Arch Pharmacol. 1974;282(3):255-60. doi: 10.1007/BF00501234. Naunyn Schmiedebergs Arch Pharmacol. 1974. PMID: 4277017 No abstract available.
• [Comparative hemolysis experiments on guinea pig and rat erythrocytes in vitro with phospholipase A and direct lytic factor from cobra (Naja naja) venom].

  Oldigs HD, Lege L, Lankisch PG. Oldigs HD, et al. Naunyn Schmiedebergs Arch Pharmakol. 1971;268(1):27-32. Naunyn Schmiedebergs Arch Pharmakol. 1971. PMID: 4250101 German. No abstract available.
• Inhibition of Na + - and K + -activated ATPase by the direct lytic factor of cobra venom (Naja naja).

  Lankisch PG, Schoner K, Schoner W, Kunze H, Bohn E, Vogt W. Lankisch PG, et al. Biochim Biophys Acta. 1972 Apr 14;266(1):133-4. doi: 10.1016/0005-2736(72)90128-9. Biochim Biophys Acta. 1972. PMID: 4261171 No abstract available.
• The red blood cell membrane as a model for targets of drug action.

  Bolis L. Bolis L. Prog Drug Res. 1973;17:59-107. doi: 10.1007/978-3-0348-7084-9_3. Prog Drug Res. 1973. PMID: 4593393 Review. No abstract available.